Xylem Inc. (NYSE:XYL) dropped -0.60% and closed the trade at $ 49.96. The company recorded a trading capacity of 1.31 million shares above its three months average daily volume of 1.12 million shares. During the last trade, shares reached to high price of $50.09 and touched the low price of $49.63. The stock’s 50-day moving average is noted at $49.35 and its 200-day moving average is stands at $44.54.
Additionally, the company has a PE ratio of 26.67 and has EPS of 1.87. The company has market capitalization of $8.95B.
Currently Xylem Inc. (XYL) captured an average recommendation of “ Overweight ” from analysts, according to FactSet data. The stock has been suggested as “Buy” from “6″ Analysts”. “0” rated “Sell” for the company. “8” said the company as a “Hold”. Overweight rating was given by “1” and Underweight rating was given by “1”.
Analysts are expecting that the company to achieve $50.00 Price Target in next 52-weeks, average price is come up through the consensus of analysts. High potential price target is set at $56.00 however minimum price target advised by analysts is $43.00. The Median price target for the stock is measured at $50.00.
Presently, Analysts decided consensus EPS estimate of $0.53 for present quarter and one month ago projected EPS estimate was at $0.53. If we take a look at back 3 month ago, consensus EPS estimate was $0.55.
A current consensus EPS estimate for next quarter is at $0.67 and 3 month ago EPS forecast was $0.68. Have a look at back 1 month ago, consensus EPS forecast was seen at $0.67.
For current fiscal year, most recent EPS estimate is set at $2.04 based on Analyst consensus and three month ago consensus EPS opinions was at $2.05. During period one month ago, consensus EPS forecast was decided at $2.04.
A current consensus EPS projection for next fiscal year is observed at $2.28 and one month ago consensus EPS forecast was at $2.27. Take a look at back three month ago, consensus EPS estimate opinions was decided at $2.28 by analysts.
One Month ago, the stock has gained consensus mean rating of Overweight based on the analysis of brokerage analyst firms polled. 6 presented the recommendations about the stock as a “Buy” signal and “Overweight” signal was reported by 0. 9 advised the “Hold” rating about this stock. 0 revealed “Sell” signal and “Underweight” rating was declared by 1.
Three Months Ago, Analysts recommended an average brokerage rating of Overweight derived from brokerage firms, according to FactSet. 7 said a “Buy Rating” and 0 announced “Overweight Rating”. 12 advised “Hold Rating” regarding the stock. 0 announced “Sell Rating” and 0 disclosed “Underweight Rating”.